|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| CURRENT ASSETS | |||
| Cash and cash equivalents | |||
| Margin cash | |||
| Trade accounts receivable | |||
| Dividends receivable | |||
| Inventories | |||
| Biological assets | |||
| Recoverable taxes | |||
| Derivative assets | |||
| Other current assets | |||
| TOTAL CURRENT ASSETS | |||
| NON-CURRENT ASSETS | |||
| Long-term investments | |||
| Recoverable taxes | |||
| Biological assets | |||
| Related party receivables | |||
| Deferred income taxes | |||
| Other non-current assets | |||
| TOTAL OTHER NON-CURRENT ASSETS | |||
| Investments in equity-accounted investees | |||
| Property, plant and equipment | |||
| Right of use assets | |||
| Intangible assets | |||
| Goodwill | |||
| TOTAL NON-CURRENT ASSETS | |||
| TOTAL ASSETS | |||
| CURRENT LIABILITIES | |||
| Trade accounts payable | |||
| Supply chain finance | |||
| Loans and financing | |||
| Income taxes | |||
| Other taxes payable | |||
| Payroll and social charges | |||
| Lease liabilities | |||
| Dividends payable | |||
| Provisions for legal proceedings | |||
| Derivative liabilities | |||
| Other current liabilities | |||
| TOTAL CURRENT LIABILITIES | |||
| NON-CURRENT LIABILITIES | |||
| Loans and financing | |||
| Income and other taxes payable | |||
| Payroll and social charges | |||
| Lease liabilities | |||
| Deferred income taxes | |||
| Provisions for legal proceedings | |||
| Related party payable | |||
| Related party payables | |||
| Derivative liabilities | |||
| Other non-current liabilities | |||
| TOTAL NON-CURRENT LIABILITIES | |||
| EQUITY | |||
| Share capital - common shares | |||
| Reserves | |||
| Accumulated other comprehensive loss | |||
| Undistributed results | |||
| Attributable to company shareholders | |||
| Attributable to non-controlling interest | |||
| TOTAL EQUITY | |||
| TOTAL LIABILITIES AND EQUITY |
Loading...